Chargement...

Robocath raises €5 million and announces the appointment of Lucien Goffart as new CEO

3 September 2019

Rouen, September 3, 2019. – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, announces today that it has raised €5 million ($5.5M) to support the rollout of its robotic platform in strategic European target markets. The company has also hired Lucien Goffart as CEO.

With twenty years of experience in interventional cardiology, Lucien Goffart has held a number of key positions in leading companies in the sector. He also has a…

Learn more

Robocath strengthens its medical advisory board with international interventional cardiology experts

21 May 2019

Rouen, France, May 21, 2019 – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, announces today that Pr Haude, Dr Lorgat and Pr Nef have joined its medical advisory board. All are global experts and recognized leaders in interventional cardiology.

The board plays a key role in defining the clinical strategy of the company. Their clinical work will contribute to the worldwide growth of robotics in interventional cardiology.

Philippe Bencteux, president…

Learn more
4 December 2019

GRCI - France

#Robocath
Subscribe to our newsletter